[Therapy of hyperlipoproteinemia type IIa, IIb and IV with Etofibrate retard].
D001786:Blood Glucose / Q000032:analysis; D002784:Cholesterol / Q000097:blood; D002994:Clofibrate / Q000627:therapeutic use*; D003404:Creatinine / Q000097:blood; D003692:Delayed-Action Preparations; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000188:drug therapy; D006953:Hyperlipoproteinemia Type IV / Q000188:drug therapy; D006951:Hyperlipoproteinemias / Q000188:drug therapy*; D008077:Lipoproteins, LDL / Q000097:blood; D008099:Liver / Q000201:enzymology; D009539:Nicotinic Acids / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood; D014527:Uric Acid / Q000097:blood
D001786:Blood Glucose; D003692:Delayed-Action Preparations; D008077:Lipoproteins, LDL; D009539:Nicotinic Acids; D014280:Triglycerides; D014527:Uric Acid; D002784:Cholesterol; D003404:Creatinine; D002994:Clofibrate
Therapie der Hyperlipoproteinämien Typ IIa, IIb und IV mit Etofibrat retard.